You are here: Home > News & Agenda > Agenda

Agenda

WORLD DAY PROGRAM OF RARE DISEASES 2019. VIII WORKSHOP "Investigate is moving forward"

February 28, 2019.

Madrid, Spain

CIBERER organizes the 8th edition of the "Investigate is Advance" Seminar that will take place on February 28 in the CaixaForum Madrid Assembly Hall (program attached). On this day, which is part of the celebrations of the World Day of Rare Diseases, researchers from the center and representatives of the affected people will present their collaboration in the search for diagnostics and new therapies. During the meeting will be addressed rare diseases undiagnosed and the current state of research in rare diseases in Spain. Also, two short videos produced by CIBERER will be released on concrete cases of successful collaboration of researchers and those affected.

Read more

European Red Cell Research Society 22nd Meeting “Red Cell Research on the Mount of Truth”

March 8 - 12, 2019

Monte Verità, Ascona, Switzerland

Red blood cell research is very dynamic, getting its new face from interdisciplinary multifaceted approaches. Clinical hematologists and researchers work side by side with engineers and pharmacologists in individual research groups, and large international consortia. Following the traditions of European Red Cell Club since its 1st meeting in Frankfurt am Main in 1976, the modern European Red Cell Society (ERCS) is at the center of these activities changing of our fundamental understanding of what red blood cells are. At the 22nd ERCS meeting, biologists, chemists, physicists, doctors, and innovative SMEs from all over the world will celebrate their achievements, exchange opinions, and move forward in merging science, translational medicine and technology related to Red Blood Cells.

Anna Bogdanova (University of Zurich) annab@access.uzh.ch Timm Schroeder (ETH Zurich) timm.schroeder@bsse.ethz.ch

Read more

International conference on ERYTHROPOIESIS CONTROL AND INEFFECTIVE ERYTHROPOIESIS: FROM BENCH TO BEDSIDE

March 15-17, 2019

Budapest, Hungary

 The main objective of this conference is to translate recent, novel data from basic research on the origin and developmental control of mega/erythroid progenitors in haematopoiesis to clinical practice. The meeting is structured with the specific aim to be translational “from bench to bedside”, and to involve participants in lively interactive discussions. It offers a unique opportunity to discuss basic science in a clinical context. This approach will notably involve the presentation and discussion of challenging clinical cases. The two and half day programme includes 9 sessions that will alternate basic science and clinical practice, with a focus on specific diseases such as CDAs, thalassaemia, SCD, haemolytic anaemias and MDS

European School of Haematology (ESH) 

Read more

Copyright © 2002 - 2019 Enerca

Co-funded by the Health Programme of the European Union.